Sign Up Today and Learn More About Biotia Stock
Invest in or calculate the value of your shares in Biotia or other pre-IPO companies through EquityZen's platform.

Biotia Stock (BIOI)
Biotia is a health tech startup offering AI-based solutions to diagnose and control infectious disease.
About Biotia Stock
Founded
2016
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Financial Services
Biotia Press Mentions
Stay in the know about the latest news on Biotia
Biotia Announces Collaboration with Mayo Clinic to Advance Microbial Identification for Infectious Disease Diagnostics
biospace • Apr 03, 2025
Metagenomic Market Research 2025-2029 - Global Market Analysis and Forecasts with Executive and Consultant Guides - A Game Changer in Diagnostics? New Technology Changes Viewpoint on Infections
globenewswire • Dec 26, 2024
Regulatory actions for November 5, 2024
bioworld • Nov 06, 2024
Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI
prnewswire • Nov 04, 2024
NYC Biotechs Rally to Test for COVID-19
fiercebiotech • Feb 11, 2022
Biotia Management
Leadership team at Biotia
Co-Founder
Chris Mason
Co-founder and CEO
Niamh O'Hara

Join now and verify your accreditation status to gain access to:
- Biotia Current Valuation
- Biotia Stock Price
- Biotia Management
- Available deals in Biotia and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Biotia Cap Table and Funding History by Share Class and Liquidity Preferences
- Biotia Revenue and Financials
- Biotia Highlights
- Biotia Business Model
- Biotia Risk Factors
- Biotia Research Report from SACRA Research
Trading Biotia Stock
How to invest in Biotia stock?
Accredited investors can buy pre-IPO stock in companies like Biotia through EquityZen funds. These investments are made available by existing Biotia shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Biotia stock?
Shareholders can sell their Biotia stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."